Sequence variants of the ligand-binding domain of the glucocorticoid receptor gene and their functional consequences on the three-dimensional protein structure.

Abstract:

:In recent years several mutations and sequence polymorphisms of the glucocorticoid receptor gene have been described. The majority of mutations have been found in patients with a rare endocrinological abnormality, the glucocorticoid resistance syndrome. In addition, some sequence polymorphisms have been considered to contribute to various diseases, but unambiguous correlations have not been established yet. Here we present the results of an in silico study, which revealed previously undescribed sequence variants of the glucocorticoid receptor gene. Although the three-dimensional structure of the DNA-binding domain of the glucocorticoid receptor has been known for several years, the crystal structure of the ligand-binding domain of the receptor has been published only recently. Using a comparative protein modelling, we analysed the structural relevance of known mutations as well as novel sequence variants discovered by our in silico approach in the ligand-binding domain of the glucocorticoid receptor. We conclude that comparative protein modelling of these mutant receptor variants offers a useful means to predict the functional consequences of amino acid replacements and to correlate structural abnormalities with clinical findings.

journal_name

Curr Med Chem

authors

Likó I,Igaz P,Patócs A,Tóth S,Pázmány T,Tóth M,Rácz K

doi

10.2174/0929867043363749

subject

Has Abstract

pub_date

2004-12-01 00:00:00

pages

3229-37

issue

24

eissn

0929-8673

issn

1875-533X

journal_volume

11

pub_type

杂志文章,评审
  • Chios gum mastic: A review of its biological activities.

    abstract::The resin of Pistacia lentiscus (L.) var. chia (Duham), an evergreen shrub belonging to the family Anacardiaceae and uniquely cultivated in southern Chios, is known as mastic. It has been used for more than 2500 years in traditional Greek medicine for treating several diseases such as gastralgia and peptic ulcers, whi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712800229014

    authors: Paraschos S,Mitakou S,Skaltsounis AL

    更新日期:2012-01-01 00:00:00

  • Fine-tuning of microRNAs in Type 2 Diabetes Mellitus.

    abstract::Type 2 diabetes mellitus is a metabolic disease widely spread across industrialized countries. Sedentary lifestyle and unhealthy alimentary habits lead to obesity, boosting both glucose and fatty acid in the bloodstream and eventually, insulin resistance, pancreas inflammation and faulty insulin production or secretio...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666171205163944

    authors: Rosado JA,Diez-Bello R,Salido GM,Jardin I

    更新日期:2019-01-01 00:00:00

  • Comparison of Clinical Outcomes Between Genders Following Antihypertensive Therapy: A Meta-Analysis.

    abstract:BACKGROUND:Numerous studies have reported sex and gender differences in the prevalence and treatment of cardiovascular diseases. However, sex differences in the therapy of hypertension have not been completely examined. OBJECTIVE:To estimate the gender-specific dissimilarity in outcomes among patients following antihy...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,meta分析

    doi:10.2174/0929867323666161213160440

    authors: Giorgini P,Sahebkar A,Stamerra CA,Raparelli V,Petrarca M,Grassi D,Ferri C,Di Giosia P

    更新日期:2017-01-01 00:00:00

  • Progress and issues of the genome-wide association study for hypertension.

    abstract::Over the past few years, use of the genome-wide association study (GWAS) has made it possible to identify the primary genetic mechanisms of essential hypertension. GWAS results have helped identify many loci in or near genes that generally were not expected to be associated with blood pressure or essential hypertensio...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666141216124537

    authors: Pan S,Naruse H,Nakayama T

    更新日期:2015-01-01 00:00:00

  • Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.

    abstract::A BRAF somatic mutation at residue 600 of the BRAF protein (BRAFV600E) is highly prevalent in papillary thyroid carcinomas (PTC). This mutation occurs in approximately 44% (from 29% to 83%) of PTC depending on the different studies. BRAFV600E is almost always found in PTC with a papillary or a mixed follicular/papilla...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710791111189

    authors: Lassalle S,Hofman V,Ilie M,Butori C,Bozec A,Santini J,Vielh P,Hofman P

    更新日期:2010-01-01 00:00:00

  • Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation.

    abstract::Thrombomodulin (TM) is a membrane protein mainly expressed by endothelial cells. It is part of the anticoagulant protein C system but recently several effects were discovered which occur independently of protein C activation. TM binds thrombin and promotes the cleavage of protein C and the thrombin activatable fibrino...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666131228204839

    authors: Wenzel J,Assmann JC,Schwaninger M

    更新日期:2014-01-01 00:00:00

  • Neuropeptide-derived antimicrobial peptides from invertebrates for biomedical applications.

    abstract::Since the beginning of the 20th century, important medicinal progress has led medical doctors to think that the end of devastating epidemics has arrived. In 1930, the discovery of sulfamides and penicillin opened a wide area of applications able to fight against bacterial infections. However, almost all antibiotics we...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986705774933470

    authors: Salzet M

    更新日期:2005-01-01 00:00:00

  • The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development.

    abstract::Factor Xa (fXa) is a critical serine protease situated at the confluence of the intrinsic and extrinsic pathways of the blood coagulation cascade. FXa catalyses the conversion of prothrombin to thrombin via the prothrombinase complex. Its singular role in thrombin generation, coupled with its potentiating effects on c...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782023659

    authors: Guertin KR,Choi YM

    更新日期:2007-01-01 00:00:00

  • Recent Progress of Benzimidazole Hybrids for Anticancer Potential.

    abstract::This review presents the detailed account of factors leading to cancer and design strategy for the synthesis of benzimidazole derivatives as anticancer agents. The recent survey for cancer treatment in Cancer facts and figures 2017 American Chemical Society has shown progressive development in fighting cancer. Researc...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190808122929

    authors: Akhtar MJ,Yar MS,Sharma VK,Khan AA,Ali Z,Haider MDR,Pathak A

    更新日期:2020-01-01 00:00:00

  • Use of Kv1.3 blockers for inflammatory skin conditions.

    abstract::Recent results using animal models of inflammatory skin conditions have shown that blockers of the voltage-gated potassium channel, Kv1.3 hold great promise for clinical utility. Kv1.3 blockers act as immunosuppressants by modulating the various subsets of inflammatory T and B cells involved in autoimmune disorders. W...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710792065072

    authors: Nguyen W,Howard BL,Neale DS,Thompson PE,White PJ,Wulff H,Manallack DT

    更新日期:2010-01-01 00:00:00

  • Implantable Medical Devices and Tissue Engineering: An Overview of Manufacturing Processes and the Use of Polymeric Matrices for Manufacturing and Coating their Surfaces.

    abstract::Medical devices are important diagnosis and therapy tools for several diseases which include a wide range of products. Technological advances in this area have been proposed to reduce adverse complication incidences. New technologies and manufacturing processes, as well as the development of new materials or medical d...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180914110119

    authors: Dutra GVS,Neto WS,Dutra JPS,Machado F

    更新日期:2020-01-01 00:00:00

  • The glioblastoma problem: targeting by combined medicinal chemistry approaches.

    abstract::Whilst knowledge of basic biology, diagnosis and prognosis of glioblastoma (GB - WHO grade IV) are steadily improving, advancements of therapy are discouragingly slow, with the only significant novelty during last ten years represented by introduction of temozolomide in chemotherapy. In order to analyze the current st...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150530210700

    authors: Frosina G

    更新日期:2015-01-01 00:00:00

  • Enzyme Inhibitors as the Attractive Targets for the Treatment of Various Diseases.

    abstract:: ...

    journal_title:Current medicinal chemistry

    pub_type: 社论

    doi:10.2174/092986732618190821115641

    authors: Orhan IE

    更新日期:2019-01-01 00:00:00

  • The palmitoylethanolamide family: a new class of anti-inflammatory agents?

    abstract::The discovery of anandamide as an endogenous ligand for the cannabinoid receptors has led to a resurgence of interest in the fatty acid amides. However, N-palmitoylethanolamine (PEA), a shorter and fully saturated analogue of anandamide, has been known since the fifties. This endogenous compound is a member of the N-a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867023370707

    authors: Lambert DM,Vandevoorde S,Jonsson KO,Fowler CJ

    更新日期:2002-03-01 00:00:00

  • Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors.

    abstract::CBP and p300 are two closely related Histone Acetyltransferases (HATs) that interact with numerous transcription factors and act to increase the expression of their target genes. Both proteins contain a bromodomain flanking the HAT catalytic domain that is important in binding of CBP/p300 to chromatin, which offers an...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190731141055

    authors: Xiong Y,Zhang M,Li Y

    更新日期:2020-01-01 00:00:00

  • Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins.

    abstract::Matrix metalloproteinases (MMPs) are essential for the degradation and turnover of components of the extracellular matrix (ECM) and, when pathologically elevated, mediate connective tissue loss (including bone destruction) in various inflammatory and other diseases. Tetracyclines (TCs) are known inhibitors of mammalia...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986712802884295

    authors: Zhang Y,Gu Y,Lee HM,Hambardjieva E,Vranková K,Golub LM,Johnson F

    更新日期:2012-01-01 00:00:00

  • Rutin as Neuroprotective Agent: From Bench to Bedside.

    abstract::Flavonoids are major dietary constituents of plant-based food found ubiquitously in plant kingdom where they are usually present in substantial amounts. Rutin is a flavonol-type polyphenol which consists of the flavonol quercetin and the disaccharide rutinose. Rutin has been reported to exert diverse biological effect...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666171003114154

    authors: Budzynska B,Faggio C,Kruk-Slomka M,Samec D,Nabavi SF,Sureda A,Devi KP,Nabavi SM

    更新日期:2019-01-01 00:00:00

  • Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional chinese medicine origin for the treatment of Alzheimer's disease.

    abstract::HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biological half-life. It has been approved as the drug for the treatment of AD in China, and marketed in USA as a dietary supplement. HupA has been the subject of investigations by a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033456747

    authors: Jiang H,Luo X,Bai D

    更新日期:2003-11-01 00:00:00

  • The atherosclerotic plaque vulnerability: focus on the oxidative and endoplasmic reticulum stress in orchestrating the macrophage apoptosis in the formation of the necrotic core.

    abstract::Although the understanding the pathophysiology of atherogenesis and atherosclerosis progression has been one of the major goals of cardiovascular research during the last decades, the precise mechanisms underlying plaque destabilization are still unknown. The disruption of the plaque and the thrombosis in the lumen th...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150311150829

    authors: Cominacini L,Garbin U,Mozzini C,Stranieri C,Pasini A,Solani E,Tinelli IA,Pasini AF

    更新日期:2015-01-01 00:00:00

  • Proteomics and cardiovascular disease: an update.

    abstract::Proteomics has unraveled important questions in the biology of cardiovascular disease and holds even greater promise for the development of novel diagnostic and prognostic biomarkers. This approach may establish early detection strategies, and monitor responses to therapies. Technological advances (most notably blue n...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986708783769713

    authors: Balestrieri ML,Giovane A,Mancini FP,Napoli C

    更新日期:2008-01-01 00:00:00

  • Astrocytic target mechanisms in epilepsy.

    abstract::Although glial proliferation of the epileptic loci is recognized for more than a century in certain focal epilepsies, the role of astrocytes in epileptic conditions is receiving significant attention only in recent years. The present review will highlight current knowledge about the various ways astrocytes control neu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867320666131119160445

    authors: Héja L

    更新日期:2014-01-01 00:00:00

  • Molecular Design and Medicinal Applications of Nano-Nitric Oxide Delivery Systems.

    abstract:BACKGROUND:Nitric oxide (NO) plays important regulatory roles in a plethora of biological functions and thus holds tremendous potential to be exploited for clinical uses. However, the chemistries in the molecular design of nano-nitric oxide delivery systems is currently lacking. OBJECTIVE:The overarching aim of this r...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170407141222

    authors: Nguyen KT,Wu Z,Huang T,Tay CY

    更新日期:2018-01-01 00:00:00

  • New aminocoumarin antibiotics from genetically engineered Streptomyces strains.

    abstract::The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A(1) are produced by different Streptomyces strains and are potent inhibitors of DNA gyrase. The biosynthetic gene clusters of all three antibiotics have been cloned and sequenced, and the function of most genes contained therein has been elucidated...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867053363063

    authors: Li SM,Heide L

    更新日期:2005-01-01 00:00:00

  • In vitro models for the study of non-alcoholic fatty liver disease.

    abstract::Non-alcoholic fatty liver disease is regarded as the hepatic manifestation of metabolic syndrome and is an important and common cause of chronic liver disease with a potential to develop end-stage liver disease. While important advances in the pathophysiology have been achieved using genetically modified and diet-indu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711794940842

    authors: Chavez-Tapia NC,Rosso N,Tiribelli C

    更新日期:2011-01-01 00:00:00

  • Sam Domains in Multiple Diseases.

    abstract:BACKGROUND:The sterile alpha motif (Sam) domain is a small helical protein module, able to undergo homo- and hetero-oligomerization, as well as polymerization, thus forming different types of protein architectures. A few Sam domains are involved in pathological processes and consequently, they represent valuable target...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666181009114445

    authors: Vincenzi M,Mercurio FA,Leone M

    更新日期:2020-01-01 00:00:00

  • COVID-19 related coagulopathy: what is known up to now.

    abstract::Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has been a global challenge. The complicated forms of the Coronavirus Disease 2019 (COVID-19) can evolve to multiple-organ failure, including several coagulopathies related to a sudden worsening of respiratory status. This article aimed to review s...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666201005112231

    authors: Pena ALB,Oliveira RA,Severo RG,Simões E Silva AC

    更新日期:2020-10-05 00:00:00

  • Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall.

    abstract::Apolipoprotein B -containing lipoproteins include triglyceride-rich lipoproteins (chylomicrons and their remnants, and very low-density lipoproteins and their remnants) and cholesterol-rich low-density lipoprotein particles. Of these, lipoproteins having sizes below 70-80 nm may enter the arterial wall, where they acc...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180530094819

    authors: Öörni K,Lehti S,Sjövall P,Kovanen PT

    更新日期:2019-01-01 00:00:00

  • Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.

    abstract::Recent advances in endoscopic techniques such as capsule endoscopy have revealed that aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) often cause mucosal lesions not only in the upper gastrointestinal tract, but also in the small intestine in humans. Gastric and duodenal lesions caused by NSAIDs can be ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712803413980

    authors: Satoh H,Takeuchi K

    更新日期:2012-01-01 00:00:00

  • Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.

    abstract::Obesity and metabolic syndrome represent major public health problems, and are the biggest preventable causes of death worldwide. Obesity is the leading risk factor for type 2 diabetes mellitus (T2DM), cardiovascular diseases and non-alcoholic fatty liver disease. Obesity-associated insulin resistance, which is charac...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320210001

    authors: Panzhinskiy E,Ren J,Nair S

    更新日期:2013-01-01 00:00:00

  • New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface.

    abstract::Lipopolysaccharide (LPS), which constitutes the lipid portion of the outer leaflet of Gram-negative bacteria, is essential for growth. It is also responsible for the variety of biological effects associated with Gram-negative sepsis. Recent advances have elucidated the exact chemical structure of this highly complex m...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711794927676

    authors: Cipolla L,Polissi A,Airoldi C,Gabrielli L,Merlo S,Nicotra F

    更新日期:2011-01-01 00:00:00